PTEN tumor suppressor serves as a major negative regulator of survival signaling mediated by PI3 kinase/ AKT/protein kinase B pathway, and is inactivated in various human tumors. Elucidation of mechanisms responsible for PTEN expression is important for providing insight into strategies to control the loss of PTEN expression in human cancers. Although recent studies suggested that p53 and Egr-1 can modulate induced PTEN expression, the mechanism responsible for ubiquitous constitutive expression of PTEN remains elusive. PTEN mRNA contains a highly conserved and GC-rich 5 0 -untranslated region (5 0 -UTR). Recently, it has been shown that the long 5 0 -UTR sequences of several growthregulated mRNAs contain promoters that can generate mRNAs with shorter 5 0 -UTRs. In this paper, we tested whether the 5 0 -UTR sequence of mouse PTEN contains a promoter that is responsible for constitutive expression of PTEN. We found that the long 5 0 -UTR sequence of mouse PTEN severely inhibits translation of PTEN and a heterologous gene firefly luciferase. Deletion of the most 5 0 -UTR sequence would enhance translation efficiency 100-fold. We also showed that the 5 0 -UTR sequence of mouse PTEN does not have an internal ribosome entry site (IRES) that can mediate cap-independent initiation of translation. Instead, we found that the 5 0 -UTR sequence of mouse PTEN contains a strong promoter that drives the production of a transcript with shorter 5 0 -UTRs, which can be translated with higher efficiency. This promoter was mapped to the region between À551 and À220 bases upstream of the translation start codon. Cotransfection analysis using Drosophila SL2 cells showed that Sp1 is one of the major transcription factors that can constitutively activate this promoter. Two endogenous PTEN transcripts with 5 0 -UTRs of 193 and 109 bases were found in DU145 and H226 cell lines. Based on these observations, we conclude that the PTEN expression may be regulated at both transcriptional and translational levels, and that the 5 0 -UTR sequence of PTEN contains a promoter that is responsible for constitutive PTEN expression.
PTEN tumor suppressor serves as a major negative regulator of survival signaling mediated by PI3 kinase/ AKT/protein kinase B pathway, and is inactivated in various human tumors. Elucidation of mechanisms responsible for PTEN expression is important for providing insight into strategies to control the loss of PTEN expression in human cancers. Although recent studies suggested that p53 and Egr-1 can modulate induced PTEN expression, the mechanism responsible for ubiquitous constitutive expression of PTEN remains elusive. PTEN mRNA contains a highly conserved and GC-rich 5 0 -untranslated region (5 0 -UTR). Recently, it has been shown that the long 5 0 -UTR sequences of several growthregulated mRNAs contain promoters that can generate mRNAs with shorter 5 0 -UTRs. In this paper, we tested whether the 5 0 -UTR sequence of mouse PTEN contains a promoter that is responsible for constitutive expression of PTEN. We found that the long 5 0 -UTR sequence of mouse PTEN severely inhibits translation of PTEN and a heterologous gene firefly luciferase. Deletion of the most 5 0 -UTR sequence would enhance translation efficiency 100-fold. We also showed that the 5 0 -UTR sequence of mouse PTEN does not have an internal ribosome entry site (IRES) that can mediate cap-independent initiation of translation. Instead, we found that the 5 0 -UTR sequence of mouse PTEN contains a strong promoter that drives the production of a transcript with shorter 5 0 -UTRs, which can be translated with higher efficiency. This promoter was mapped to the region between À551 and À220 bases upstream of the translation start codon. Cotransfection analysis using Drosophila SL2 cells showed that Sp1 is one of the major transcription factors that can constitutively activate this promoter. Two endogenous PTEN transcripts with 5 0 -UTRs of 193 and 109 bases were found in DU145 and H226 cell lines. Based on these observations, we conclude that the PTEN expression may be regulated at both transcriptional and translational levels, and that the 5 0 -UTR sequence of PTEN contains a Introduction PTEN/MMAC1/TEP1 (referred as PTEN in the remaining text of this paper) is a tumor suppressor gene that maps to the 10q23.3 and has been shown to be deleted or mutated in many human tumors including glioblastomas, endometrial neoplasms, hematological malignancies, and prostate and breast cancers (Ali et al., 1999; Cantley and Neel, 1999; Dahia, 2000; Di Cristofano and Pandolfi, 2000) . In addition, germline mutations in PTEN cause Cowden syndrome (CS), characterized by multiple hamartomas and a high proclivity for developing cancer (Cantley and Neel, 1999) . Although PTEN sequence is highly homologous with dual-specificity protein phosphatase, its major substrate is phosphatidylinositol triphosphate (PIP 3 ). It has been suggested that PTEN is a major negative regulator of PIP 3 and negatively regulates the survival signaling mediated by the PI3 kinase/AKT/protein kinase B pathway (Maehama and Dixon, 1999; Leslie and Downes, 2002) . Loss of PTEN function or expression results in an increased concentration of PIP 3 and AKT hyperactivation, which leads to the protection of cells from various apoptotic stimuli (Stambolic et al., 1998) . In contrast, overproduction of PTEN induces growth suppression via cell cycle arrest and/or induction of apoptosis, and inhibits cell adhesion and migration (Dahia, 2000) . Recently, PTEN has been demonstrated to serve as a negative regulator for proliferation of human neural stem cells and mammary epithelial cells (Backman et al., 2001; Groszer et al., 2001; Kwon et al., 2001; Li et al., 2002) . With the critical role in antagonizing PI3 kinase pathways, PTEN is anticipated to be the target of complex control mechanisms (Leslie and Downes, 2002) . However, very little is known about the regulation of PTEN expression. PTEN expression is ubiquitous and constitutive, while it can also be altered by various biological stimuli. It was reported that PTEN expression in human keratinocytes decreased when the cells were treated with TGF-b (Li and Sun, 1997) and PTEN expression increased dramatically when myeloid leukemia cells were induced to differentiate into either granulocytic or monocytic cells (Hisatake et al., 2001) . PTEN expression is also induced during neuronal differentiation (Ross et al., 2001) . It has been reported that PTEN expression can be induced by p53 and Egr-1, and functional p53 and Egr-1 binding sites were identified between bases À1190 and À1157, and between À947 and À939 upstream of the translation start codon Virolle et al., 2001) , respectively. This observation suggests that p53 and Egr-1 may be able to modulate the PI3 kinase/AKT/Protein kinase B pathway via regulating PTEN expression . However, mechanisms responsible for constitutive expression of PTEN remain to be identified.
Recently, we proposed that promoters may exist in the long 5 0 -UTR sequences of genes related to cell growth (Han and Zhang, 2002) . In this study, we attempted to address this hypothesis by studying the regulation mechanism of PTEN expression. Examination of the 5 0 untranslated region (5 0 -UTR) of PTEN messenger RNA (mRNA) revealed several interesting features related to translational regulation. First, the 5 0 -UTR of PTEN mRNA is about 1 kb inferred from cDNA sequences of both mouse (GeneBank Accession number NM_008960) and human (GeneBank Accession number NM_000314) PTEN and confirmed by reverse transcription-polymerase chain reaction (RT-PCR) ). This length of 5 0 -UTR is significantly longer than the average length of 100-300 bases for eucaryotic 5 0 -UTRs. Second, the 5 0 -UTR of both mouse and human PTEN mRNA contains four upstream translation start codons. Third, the 5 0 -UTR of PTEN mRNA is G/C-rich with a predicted complex secondary structure. Lastly, the 5 0 -UTRs of both human and mouse PTEN mRNA are well conserved with an overall homology of 490%. These features of PTEN mRNA strongly suggest that the 5 0 -UTR of PTEN may inhibit efficient translation initiation by the conventional cap-dependent ribosome scanning mechanism. It is possible that PTEN mRNAs use other mechanisms such as internal ribosome entry site (IRES) to initiate translation (for reviews see Pestova et al. (2001) and Sachs (2000) ). Alternatively, the long 5 0 -UTR of PTEN may contain a promoter or splice site to generate mRNA species with significantly shorter 5 0 -UTRs (Kozak, 2001; Schneider and Kozak, 2001) , which can be translated efficiently (Han and Zhang, 2002) .
In this study, we tested these possibilities and found that mRNAs with long 5 0 -UTRs of PTEN cannot be translated by the cap-dependent mechanism, whereas the mRNAs with shorter 5 0 -UTRs can. The long 5 0 -UTR of PTEN does not contain an IRES element to mediate IRES-dependent translation initiation. Instead, we demonstrated that the 5 0 -UTR of PTEN contains a strong promoter that produces mRNA with shorter 5 0 -UTRs. Using 5 0 RACE and RNase protection assay, we found two endogenous PTEN transcripts with short 5 0 -UTRs of 109 and 193 bases, respectively, in human cancer cell lines. These mRNA species with shorter 5 0 -UTRs may be responsible for constitutive production of PTEN proteins. Interestingly, the promoter region in the 5 0 -UTR overlaps with the hypermethylated region identified in gastric tumor (Kang et al., 2002) and endometrial carcinoma (Salvesen et al., 2001) , implicating that hypermethylation of this promoter may be important for the loss of PTEN expression observed in a number of tumors.
Results

The Long 5
0 -UTR of mouse PTEN mRNA inhibits translation in vitro
The 5 0 -UTR of mouse PTEN mRNA is 948-nucleotide long and contains 72% G and C residues. Analysis of the 5 0 -UTR using Zuker's mfold program (version 3.0) (Mathews et al., 1999) showed that this region has potential to form various secondary structures and all of the structures predicted are extremely stable with a typical free energy as high as À432 kcal/mol, which is well beyond the energy shown to inhibit ribosome scanning. In addition, this region is also punctuated with four translation start codon AUGs that encode two short upstream open reading frames (uORFs) with 36 and 45 amino acids, respectively (two of the AUGs are located at the end of the first uORF in the same frame). Both uORFs end before À551 bases upstream of the physiological translation start codon. Generally, uAUGs or uORFs inhibit translation of the main ORF by interfering with the scanning process of the 40S ribosome complex. To analyse the effect of the 5 0 -UTR sequence of mouse PTEN on translation, we utilized an in vitro transcription and translation system. Mouse PTEN cDNA with (pG-WPTEN) and without (pG-DPTEN) the 5 0 -UTR sequence ( Figure 1a ) were cloned into pGEM-4Z under the control of an SP6 promoter. Run-off transcripts were generated by SP6 RNA polymerase, purified and quantified (Figure 1b) , and an equal amount of RNAs were used to program cell-free translation in rabbit reticulocyte lysate (RRL). As shown in Figure 1c , no full-length PTEN protein was translated from transcripts containing the long 5 0 -UTR (WPTEN) (lane 1), whereas a significant amount of PTEN protein (DPTEN) was generated in the absence of the 5 0 -UTR sequence (lane 2). Clearly, the presence of the long 5 0 -UTR sequence drastically inhibits the translation of PTEN in RRL.
To analyse whether the protein-encoding sequence (ORF) influences the translational inhibition effect of the 5 0 -UTR, we cloned the 5 0 -UTR sequence of PTEN immediately upstream of an open reading frame encoding firefly luciferase (LUC) in a pGEM-4Z-based reporter vector, pG-LUC, resulting in the plasmid pG-5 0 LUC (Figure 1a) . This construct was then used to program in vitro transcription ( Figure 1b ) and cell-free translation ( Figure 1d ) as described above. Again, the translation programmed by the pG-LUC transcript generated a significantly increasing amount of firefly LUC activity proportional to the amount of transcripts used, while no LUC activity was detected from the translation programmed by pG-5 0 LUC transcripts. Thus, the 5 0 -UTR sequence of mouse PTEN inhibits translation of transcripts encoding a heterologous protein and is independent of the protein-encoding sequence.
To further analyse the translational inhibition effect of the 5 0 -UTR sequence of PTEN, we generated several sequential deletion mutants from the 5 0 end of the 5 0 -UTR in pG-5 0 LUC constructs (Figure 2a ). These deletion mutants contain putative secondary structures with different free energies from À367 to À16 kcal/mol predicted by Zuker's mfold program (Mathews et al., 1999) . As shown in Figure 2b , translation of firefly LUC was very inefficient for transcripts with 5 0 -UTRs that have 479 nucleotides or longer. Further deletion resulted in an increase in translation. However, significant translation occurred only to the transcript with 93 bases of the 5 0 -UTR sequence with a predicted energy of À16 kcal/mol. It is B100-fold more translatable than the full-length transcript. These results are consistent with a model that the stable secondary structure in the 5 0 -UTR sequence of PTEN mRNA inhibits the ribosome scanning process for cap-dependent translation initiation.
5 0 -UTR sequence of PTEN enhances expression of the second cistron in dicistronic test
The above results clearly demonstrate that the 5 0 -UTR of PTEN mRNA can effectively suppress ribosome scanning in vitro. However, PTEN protein has been reported to be constitutively expressed and its expression can be induced to a high level by biological stimulation. Thus, if PTEN mRNA with the full-length 5 0 -UTR is translated, it may use an alternative mechanism such as IRES-mediated translation initiation. To test this hypothesis, the 5 0 -UTR (À828 to À1 bases) of PTEN was cloned into the intergenic region of a dicistronic vector pRF to obtain pR-PTEN-F (Figure 3a) . The internal ribosome entry site (IRES) sequence of human rhinovirus (HRV) was engineered in the same way and was used as a positive control. The pRF-based constructs contain an SV40 promoter to direct the transcription of dicistronic RNA encoding Renilla LUC as the first cistron and firefly LUC as the second cistron. Translation of the first In vitro transcription and translation. The deletion mutants were used to generate in vitro transcripts (bottom), which were then used to program cell-free translation in RRL. LUC activities of the translated products were measured by enzymatic assays as described in Materials and methods
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0 -UTR B Han et al cistron (Renilla LUC) serves as an indicator of capdependent translation, while translation of the second cistron (firefly LUC) reflects the IRES activity-associated with the inserted intergenic sequence. This approach is considered as a 'gold standard' for characterizing cellular IRES (Sachs, 2000) . These dicistronic constructs were transfected into HeLa cells and both Renilla and firefly LUC activities were measured. As shown in Figure 3b , the 5 0 -UTR sequence of PTEN stimulated the expression of firefly LUC by B70-fold over negative vector control and about 2-3-fold over positive pR-HRV-F control. Similar results were also obtained using another cell line H1299 (data not shown). These results suggest that the 5 0 -UTR sequence of PTEN may contain an IRES element or it may enhance read-through or jumping from the first cistron.
To determine whether the effect of the 5 0 -UTR sequence of PTEN on the translation of the second cistron is due to enhanced read-through or jumping from the first cistron, we inserted a synthetic hairpin in front of the first cistron and created phRF and phR-PTEN-F (Figure 3a) . The hairpin structure has a free energy of À40 kcal/mol and is expected to significantly inhibit the cap-dependent translation initiation of the first cistron. Therefore, it will decrease potential ribosome read-through or jumping but will not affect the translation from IRES-mediated initiation of the second cistron. As shown in Figure 3c , the insertion of the hairpin resulted in B90% decrease of the Renilla LUC activity (first cistron) in both phRF and phR-PTEN-F as compared with pRF and pR-PTEN-F, respectively, suggesting that the hairpin structure inhibits the capdependent translation. However, the level of firefly LUC activity (second cistron) produced by phR-PTEN-F was not significantly affected when compared with pR-PTEN-F. This result suggests that the enhanced expression of the second cistron by the 5 0 -UTR sequence of PTEN was independent of the cap-dependent translation initiation of the first cistron. Thus, it is not due to enhanced read-through or jumping from the first cistron.
To define the boundaries in the 5 0 -UTR sequence of PTEN for enhancing expression of the second cistron, a series of deletion mutants of the 5 0 -UTR of PTEN were engineered for a dicistronic assay in HeLa cells ( Figure 4a ). As shown in Figure 4b , deletion from both ends of the 5 0 -UTR resulted in a gradual decrease in stimulating firefly LUC expression. A construct pR-hPTEN-F that Similar results with these constructs have also been observed by using another cell line H1299 (data not shown). Since the deletion mutant D828-551 and D220-1 retains the most enhancing activity, the 230-nucleotide central region of the 5 0 -UTR (À551 to À220) may contain important elements for stimulating firefly LUC expression. It is noteworthy that deletion mutants that retain about 200 nucleotides of the 5 0 -UTR sequence at the 3 0 -end (D828-257) or at the 5 0 -end (D474-1) still have the enhancing activity comparable to HRV IRES, suggesting that the enhancing activity also exists at both 5 0 -and 3 0 -ends of the 5 0 -UTR sequence of PTEN.
5 0 -UTR of PTEN does not display an IRES activity in dicistronic mRNA assay
The above results suggest that the 5 0 -UTR of PTEN may (1) contain an IRES activity that enhances the translation of firefly LUC from the dicistronic mRNA by internal initiation (for reviews see Pestova et al. (2001) and Sachs (2000) ), (2) contain a promoter that directs transcription of the firefly LUC gene (Han and Zhang, 2002) , and/or (3) contain a splicing acceptor site, that creates a splicing variant with only the second cistron of the firefly LUC gene. To distinguish between these possibilities, we generated dicistronic RNAs in vitro from the dicistronic constructs and used them to program translation both in HeLa cells and in RRL. RNA transfection allows a direct analysis of whether the 5 0 -UTR sequence of PTEN in the intergenic region of a dicistronic mRNA can enhance the translation of the second cistron without transcriptional interference. For purposes of RNA transfection, plasmids pSP-RF A30 , pSP-R-PTEN-F A30 , and pSP-R-HRV-F A30 were engineered and used for producing dicistronic transcripts containing m 7 GpppG cap and polyadenylated tail in vitro (Figure 5a ). The in vitro transcripts were introduced into HeLa cells by lipofectin encapsulation. At 8 h following transfection, cell lysates were prepared for LUC activity measurement. As expected, the firefly LUC of vector RNA was very poorly translated and its activity (arbitrary units) only represented about 0.16% of Renilla LUC (data not shown). It increased to about 6.7% with the dicistronic RNAs containing HRV IRES. Therefore, HRV IRES significantly stimulated the translation of firefly LUC about 40-fold over vector control (Figure 5b ). However, no stimulation of firefly LUC expression was observed with the 5 0 -UTR of Relative luciferase activities generated from constructs containing the wild-type and mutant 5 0 -UTR sequences of mouse PTEN. HeLa cells were transfected with the constructs shown in (a), and 24 h following transfection, Renilla and firefly LUC activities were measured and the ratio of firefly to Renilla LUC was calculated and normalized to the wild-type (WT) control. The empty vector pRF and the plasmid containing HRV IRES were also used as negative and positive controls, respectively. The data were from three independent experiments 0 -UTR of PTEN was about 0.003% of Renilla LUC activity, significantly less than that observed with vector control. Again, this observation confirms the conclusion that the presence of the 5 0 -UTR sequence of PTEN significantly prevents ribosome scanning initiated from the 5 0 end. Similar results were observed using the dicistronic RNA transcripts to program cell-free translation in RRL supplemented with HeLa extract (data not shown). Thus, it appears that the 5 0 -UTR sequence of PTEN does not contain an IRES element to mediate internal ribosome entry.
5
0 -UTR sequence of PTEN contains a ubiquitously functional promoter
The above results prompted us to explore whether the 5 0 -UTR sequence of PTEN contains a promoter. For this purpose, we used a promoterless dicistronic assay as described previously (Han and Zhang, 2002) by simply removing the unique SV40 promoter together with the intron sequence from the pRF-based dicistronic constructs. These promoterless dicistronic constructs ( Figure 6a ) were then transfected into HeLa cells for determination of both Renilla and firefly LUC activities ( Figure 6b ). As we have shown previously (Han and Zhang, 2002) , both the Renilla and firefly LUC activities were minimal, but detectable for pRF(-P) vector control. Only a twofold increase in firefly LUC activity was observed with pR-HRV-F(-P) construct. This small increase was in dramatic contrast with the 30-fold increase associated with the pR-HRV-F construct (Figure 3b) . Thus, the enhanced expression of firefly LUC from pR-HRV-F construct was not due to production of monocistronic transcripts by a promoter present in the HRV sequence. However, the pR-PTEN-F(-P) construct generated more than 160-fold firefly LUC activity over vector control. Thus, the significant stimulation of the firefly LUC expression by the 5 0 -UTR sequence of PTEN was likely due to the presence of a strong promoter in this region.
The existence of a constitutively active promoter in the 5 0 -UTR sequence of PTEN is unexpected and may help explain the relatively constant and high levels of PTEN mRNA and protein in most primary cells . To determine whether this promoter is ubiquitously used, we analysed its activity in various human cell lines including HEK293 (transformed primary embryonic kidney cells), H1299 (largecell lung carcinoma cells), K562 (erythroleukemia cells), and DU145 (prostate cancer cells). As shown in Figure 6c , the 5 0 -UTR sequence displays significant promoter activities in all the cell lines tested, at a level similar to that observed in HeLa cells. Thus, this promoter in the 5 0 -UTR of PTEN is ubiquitously and constitutively active.
To determine directly whether the transcript derived from the promoter in the 5 0 -UTR sequence of PTEN exists in cells, poly(A) mRNAs were isolated for Northern blot analysis 24 h following transfection of pRF, pR-PTEN-F, pR-PTEN-F(-P), and pRF(-R). The pRF(-R) construct, which lacks the Renilla LUC gene (Han and Zhang, 2002) , was used as a monocistronic control. This vector is expected to produce transcript encoding only firefly LUC using the SV40 promoter. The pRF vector was used as a dicistronic control, which produces only dicistronic mRNA using SV40 promoter. As shown in Figure 7 , dicistronic transcript from control pRF (lane 1, indicated by an asterisk) and the monocistronic transcript from control pRF(-R) (lane 4, indicated by an arrowhead) were detected as expected. The dicistronic transcript from pR-PTEN-F (lane 2, indicated by an asterisk) is bigger than that from pRF (lane 1), consistent with the presence of the 5 0 -UTR sequence of PTEN in the intergenic region. The transcript produced from pR-PTEN-F(-P) has a size slightly larger than that from pRF(-R) (compare lanes 3 and 4), suggesting that it is a monocistronic mRNA produced by the promoter in the 5 0 -UTR of PTEN. The same monocistronic transcript was also observed with pR-PTEN-F (lane 2, indicated by an arrowhead). These observations confirm that the 5 0 -UTR sequence of PTEN has a strong promoter for transcription of the second cistron firefly LUC. It is noteworthy that the monocistronic RNA bands from both pR-PTEN-F and pR-PTEN-F(-P) on Northern blot (lanes 2 and 3, indicated by an arrowhead) are much wider than that 0 -UTR sequence of mouse PTEN contains a ubiquitously active promoter. (a) Schematic diagram of promoterless dicistronic construct of pRF(-P), pR-HRV-F(-P), and pR-PTEN-F(-P). The sequences of SV40 promoter and chimeric intron were removed from the parental dicistronic constructs shown in Figure 3 . (b) Relative LUC activities generated from the promoterless dicistronic constructs. The promoterless constructs were transfected into HeLa cells, and 24 h following transfection, cells were harvested for determination of Renilla and firefly luciferase activity. The relative ratios between firefly and Renilla LUC activities were calculated and normalized to that of the vector-transfected cells (pRF (-P)). (c) Promoter activity of the 5 0 -UTR sequence in various human cell lines. Human H1299, K562, HEK293, and DU145 cells were transfected with promoterless constructs and cell lysates were prepared 24 h following transfection for LUC measurement as described for HeLa cells in panel b. Relative promoter activity was calculated as the ratio of firefly LUC activity of pR-PTEN-F(-P) to the vector control pRF(-P). The data were from three independent experiments Transactivation of the promoter in the 5 0 -UTR sequence of PTEN by Sp1
To identify the boundaries of the DNA region that are responsible for promoter activity, deletion mutants were generated from either 5 0 or 3 0 ends of the 5 0 -UTR of PTEN (Figure 8a ). These deletion mutants were engineered into the promoterless dicistronic vector and then used to determine their ability to direct firefly LUC expression. As shown in Figure 8b , deletion from either end of the 5 0 -UTR resulted in a gradual decrease in stimulating firefly LUC expression. The full stimulation activity resides in the region of À551 to À220 since deletion mutants D828-551 and D220-1 still contain fullpromoter activity. In addition, the deletion mutants containing only the 5 0 (D474-1) or 3 0 (D828-257) region of the 5 0 -UTR sequence also have significant promoter activity. Widespread promoter activity within the 5 0 -UTR sequence of PTEN may be responsible for multiple transcriptional initiation sites observed with Northern blots. These observations are consistent with the results obtained from conventional dicistronic DNA constructs (see Figure 4) .
Analysis of the potential transcription factor binding sites in the À551 to À220 region of the 5 0 -UTR sequence using MatInspector (Quandt et al., 1995) showed several consensus sites for transcription factors such as Sp1, Ets-1, Egr-1, Ap-1, Ap-2, and Ap-4 (Figure 9a ). To determine directly whether the above transcription factors could functionally modulate promoter activity in the 5 0 -UTR sequence of PTEN, Drosophila SL2 cells, which are deficient in Sp1-, Sp3-, and Ets-related proteins (Courey and Tjian, 1988; Dennig et al., 1996) , were used. The reason for using insect instead of mammalian cells is that Sp1-, Sp3-, and Ets-related factors are expressed in virtually all mammalian cells, which could affect the interpretation of this experiment. We introduced the pR-PTEN-F(-P) construct along with Drosophila expression plasmids pPacSp1 or pPacUEts-1 into Drosophila SL2 cells. As shown in Figure 9b , pPacSp1 stimulated the promoter activity in the 5 0 -UTR sequence of PTEN by 15-fold, whereas it stimulated vector control only by threefold. Ets-1 did not significantly stimulate the promoter activity in the 5 0 -UTR sequence of PTEN. These results suggest that Sp1 is a possible transcription factor that regulates the constitutive expression of PTEN by acting at the promoter within the 5 0 -UTR of PTEN. Since there are several Sp1 binding sites in the 5 0 -UTR sequence, it remains to be determined which Sp1 element is responsible for the promoter activity.
Detection of endogenous transcripts originating from the 5 0 -UTR promoter in human cancer cell lines
Previous research with human PTEN using Northern blot detected heterogeneous transcripts of a variety of Relative LUC activity generated from the wild-type and mutant 5 0 -UTR sequences of mouse PTEN. HeLa cells were transfected with the constructs shown in (a), and 24 h following transfection, Renilla and firefly LUC activities were measured and the ratio of firefly to Renilla LUC was calculated and normalized to the wild-type (WT) control. The data were from three independent experiments Regulation of PTEN expression by 5 0 -UTR B Han et al sizes between 2 and 5 kb (Whang et al., 1998) . This heterogeneity might partly be due to the existence of different promoters, such as the ones discussed above, and different transcription start sites. To test this hypothesis and to determine whether endogenous PTEN transcripts with a shorter 5 0 -UTR sequence exist, we performed 5 0 rapid amplification of cDNA ends (RACE) and an RNase protection assay using RNAs isolated from the human prostate cancer cell line DU145 and human lung cancer cell line H226, which are known to express PTEN (Whang et al., 1998; Soria et al., 2002) . As shown in Figure 10a , multiple products with various lengths ranging from about 150 to 1100 bp were produced from 5 0 RACE using gene-specific primer 10-bases upstream of the translation start codon ATG (Figure 10c ). This observation indicates that PTEN transcripts in DU145 cells have different 5
0 -UTRs and likely multiple transcription start sites exist, consistent with our findings shown in Figures 7 and 8 . The two small products (indicated by asterisks) were then excised from the gel, cloned, and sequenced. The sequencing data (Figure 10a ) suggest that the two small transcripts are products from transcription start sites at À109 and À193 bases upstream of the translation start codon, respectively. This observation is consistent with our promoter mapping, which showed that the 5 0 -UTR promoter resides in the region between À551 and À220 ( Figure 8 ).
As an independent approach to demonstrate the existence of endogenous PTEN transcripts with shorter 5 0 -UTRs, we performed an RNase protection assay. Using a probe covering the region of À483 to À60 in the 5 0 -UTR sequence of human PTEN (Figure 10c ), we generated three protected products with estimated sizes of 360, 135, and 59 bases, respectively, with RNAs isolated from both DU145 and H226 cell lines ( Figure  10b ). However, no protected RNAs were found with yeast tRNA control. While the products of 135 and 59 base bands are likely derived from transcripts with 5 0 -UTRs of 109 and 193 bases as shown by 5 0 RACE, respectively, the product of 360 bases is possibly produced from the transcripts with a longer 5 0 -UTR. Together, these results demonstrate that endogenous PTEN transcripts with shorter 5 0 -UTRs exist in human cell lines and they are likely responsible for efficient translation to produce proteins.
Discussion
Whereas efficiently translated mRNAs, such as cellular transcripts that encode globins and some viral mRNAs, have rather short 5 0 UTRs (o100 bases), many mRNAs encoding oncogene products or factors related to cell growth have long 5 0 -UTRs (Kozak, 1987 (Kozak, , 1991 . In many cases, the long 5 0 -UTR presents a hindrance to cap-dependent translation initiation (Willis, 1999) . How such mRNAs are translated remains to be answered. As one of the alternative mechanisms, IRES-mediated translation initiation has recently been proposed and demonstrated for some of these mRNAs. With this mechanism, ribosome is directly recruited to the translation start codon, thereby overcoming the translational inhibition by the long and structured 5 0 -UTR sequence (Willis, 1999; Sachs, 2000; Pestova et al., 2001) . However, the existence of such a mechanism is recently questioned and argued (Kozak, 2001; Schneider and Kozak, 2001) . Furthermore, detailed analysis of the reported IRES element in the 5 0 -UTR sequence of eIF4G (Gan & Rhoads, 1996; Gan et al., 1998) demonstrated that it is in fact a promoter (Han and Zhang, 2002) . It was also found that the long 5 0 -UTRs of human Sno and mouse Bad contain promoters, suggesting that promoters in the 5 0 -UTR sequences are more prevalent than anticipated. These observations led us to hypothesize that promoters in the 5 0 -UTR sequence provide an alternative way of producing a translatable mRNA with shorter 5 0 -UTRs (Han and Zhang, 2002) .
The long and structured 5 0 -UTR sequence of PTEN mRNA is highly conserved between mouse and human. Conservation of the 5 0 -UTR sequence is also observed for other proto-oncogenes or factors such as VEGF and PDGF (Bernstein et al., 1997; Huez et al., 1998) . The conservation of the 5 0 -UTR sequences suggests that they may play an important role in regulating gene expression. In this report, we showed that the 5 0 -UTR sequence of PTEN inhibits translation of its downstream 0 -UTR of only 93 bases is 100-fold more translatable than the transcript with a long 5 0 -UTR of 828 bases. The inhibitory effect of the long 5 0 -UTR is similar to that of the 5 0 -UTR of PDGF, which inhibits translation about 40-fold (Rao et al., 1988) .
Inhibition of translation by 5 0 -UTR led us to explore other mechanisms such as IRES that may be used for PTEN translation. The 5 0 -UTR sequence of PTEN enhanced the expression of the second cistron by about 70-fold in the traditional dicistronic DNA assays and translation of the second cistron persisted when a hairpin structure was used to block translation of the first cistron (Figure 3) . However, no such enhancing activity was observed in the dicistronic RNA assay, indicating that the 5 0 -UTR of PTEN may not have IRES. This conclusion is supported by our promoterless dicistronic test, which revealed that the enhancing effect was due to the existence of promoter activities in the 5 0 -UTR of PTEN. In addition, Northern blot analysis clearly detected the monocistronic transcript derived from the promoter in the 5 0 -UTR sequence of PTEN ( Figure 7 ). By construction of a variety of deletion mutants from both 5 0 and 3 0 end of the 5 0 -UTR, we mapped the promoter activity to the region À551 to À220. Our experiments using Drosophila SL2 cells showed that the promoter in the 5 0 -UTR sequence of PTEN responds to Sp1, a ubiquitous transcription factor that is not only important for constitutive expression of many house-keeping genes but also critical for induced expression of many growth-related genes (Black et al., 2001) . Finally, using the RNase protection assay and 5 0 RACE, we identified two endogenous PTEN transcripts with short 5 0 -UTRs of 109 and 193 bases in both human cancer cell lines H226 and DU145, which were known to express human PTEN (Whang et al., 1998; Soria et al., 2002) .
In the past, promoters in the 5 0 -UTR sequences have primarily been ignored and lack attention. Promoter studies normally begin with primer extension aiming at identification of the transcription start site furthest away from the translation initiation start codon. Subsequent analysis usually focuses on the promoter regions that are responsible for the generation of the transcript with the 0 -UTR. Few of the past studies considered the impact of translational regulation and the fact that mRNAs with long 5 0 -UTRs generated by the promoter they studied may not be translatable. For the same reason, the reporter activity detected in the presence of both the upstream promoter and the long 5 0 -UTR sequence might be due to the contribution of another promoter in the 5 0 -UTR sequence that produces a transcript with a shorter 5 0 -UTR. Consequently, many promoters in 5 0 -UTRs were never discovered. Such a strategy may introduce confusion to the researchers in the translation field who are working to understand how mRNAs with long 5 0 -UTRs can be translated. In the case of the PTEN promoter study, Stambolic et al. (2001) , using a conventional approach, identified that the transcription start site for transcripts with the longest 5 0 -UTR was located between À951 and À925 bases upstream of the translation start codon. However, our studies showed that a transcript with more than 500 bases of 5 0 -UTR could not be translated efficiently and it does not appear to contain IRES. The question thus remains as to how the mRNA of PTEN with a 5 0 -UTR of 925-950 bases is translated. Use of the promoter in the 5 0 -UTR sequence to produce mRNAs with shorter 5 0 -UTRs would provide a solution to this problem. In fact, of the 100 EST clones found by searching the GeneBank using the 5 0 -UTR of mouse PTEN as a query sequence, 50 clones may have a 5 0 -UTR less than 500 bases. Our RACE and RPA study (Figure 10 ), promoter mapping (Figure 8) , and Northern blot analysis (Figure 7) suggested the existence of transcripts with various lengths of 5 0 -UTR. Furthermore, using RPA and 5 0 RACE, we identified two endogenous transcripts with 5 0 -UTRs of 109 and 193 bases, respectively, that are likely originated from the 5 0 -UTR promoter. However, this possibility was not considered in the Stambolic et al. (2001) study and a large part (427 bp immediately upstream of the translation start codon) from the 5 0 -UTR sequence of PTEN was deleted in their constructs. By doing so, their promoter activity is only fourfold over the vector control as compared to about 100-fold shown in our study (Figure 6 ). They, therefore, failed to explain the p53-independent, relatively high and constant expression of PTEN mRNA and protein in a variety of cells.
In another study (Virolle et al., 2001) , the transcription start site at À1013 bases upstream of the translation start codon was considered simply based on the longest cDNA sequence of human PTEN. Nevertheless, the whole 5 0 -UTR sequence was used, which led to the identification of the Egr-1 factor binding site located downstream of the postulated transcription start site. However, the existence of promoters in the 5 0 -UTR sequence, which may direct alternative transcription compatible with translation, was not considered. Although not discussed in their study, their results are consistent with ours in the present study. Furthermore, they also showed that the promoter activity in the 5 0 -UTR is about half of that generated in the presence of both 5 0 -UTR and the upstream promoter. Again, these data were not discussed and they still considered in their figures that the transcription start site is located at the upstream. This type of routine practice in promoter studies will likely generate incorrect conclusions on the regulation of gene expression, specifically for PTEN because it is known that the mRNAs of PTEN with long 5 0 -UTRs cannot be translated. Our observations also confirm that the translation of PTEN mRNAs is regulated by the secondary structure of their 5 0 -UTRs. Only mRNAs with shorter 5 0 -UTRs that have less free energy in secondary structure can be significantly translated. Retrospectively, it is noteworthy that human PTEN transcripts of heterogeneous sizes between 2 and 5 kb are observed on Northern blot (Whang et al., 1998) . Our RPA and 5 0 RACE results (Figure 10 ) demonstrated that 5 0 -UTRs of endogenous PTEN mRNAs in human cancer cell lines are heterogeneous at least in their length with the 5 0 -UTRs. Interestingly, in the human PTEN promoter study (Virolle et al., 2001) , the D3 0 transcript with a short 5 0 -UTR (B258 bases) has a much higher basal and Egr-1-stimulated expression than the transcript with a longer 5 0 -UTR (B1031). Although these authors were focusing on the positive and negative elements responsible for transcriptional regulation of PTEN expression, it cannot be ruled out that the transcripts with a short 5 0 -UTR are in fact translated with higher efficiency than the transcripts with a long 5 0 -UTR. Furthermore, the relative abundance of PTEN mRNA does not correlate well with its protein level in advanced prostate cancer tissues as compared with normal tissues (Whang et al., 1998) , suggesting that translational control may play an important role in regulating PTEN expression.
Since the promoter in the 5 0 -UTR, which was mapped to the region between À551 and À220 bases upstream of the translation start codon, contributes to production of translation-compatible transcripts, and functions in a variety of cell lines tested (Figure 6 ), it is tempting to suggest that the promoter in the 5 0 -UTR is a major promoter that controls ubiquitous and constitutive PTEN protein production. Upstream promoters or enhancers may function through regulating the production of transcripts from the promoter in the 5 0 -UTR. Switching off the 5 0 -UTR promoter will, therefore, lead to reduced or complete loss of PTEN expression. Like many other tumor suppressor genes, expression of PTEN has been postulated to be regulated by epigenetic mechanisms. PTEN expression can be lost or greatly reduced in some tumors without any mutation in the coding sequence of the PTEN gene in endometrial, breast, prostate, ovarian, non-small cell lung cancer, and melanocytic tumors (reviewed in Mutter, 2001; Leslie and Downes, 2002; Soria et al., 2002) . This is supported by an observation that PTEN expression in the prostate cancer xenograff LuCap-35 and lung cancer cell line H1299 was recovered upon treatment with the demethylating agent 5-azadeoxycytidine (Whang et al., 1998; Soria et al., 2002) . However, the detailed mechanism underlying epigenetic regulation of PTEN expression is yet to be identified. In this respect, it is interesting to note that the 5 0 -UTR-encoding sequence of both human and mouse PTEN contains two CpG islands, which may Regulation of PTEN expression by 5 0 -UTR B Han et al be potential methylation targets as predicted using an online program (http://www.ebi.ac.uk/emboss) (data not shown). Indeed, the presence of methylation in the 5 0 -UTR sequences (À405 to À104) was reported to be frequent in both endometrial and gastric carcinomas (Salvesen et al., 2001; Kang et al., 2002) . This region with high frequency of methylation overlaps with the region containing the promoter mapped in this study (À551 to À220). Methylation of this region may shut off 5 0 -UTR promoter activity and constitutive expression of PTEN and, therefore, inactivate the expression of PTEN in some tumors. We are currently testing this hypothesis by determining the effect of methylation of the 5 0 -UTR sequence on promoter activity.
Since the promoter in the 5 0 -UTR sequence of PTEN may serve as a major promoter controlling constitutive expression of PTEN, detailed promoter mapping may lead to discovery of cis-elements and transcription factors that govern constitutive PTEN expression. Analysis of putative transcription factor binding sites showed that the promoter in the 5 0 -UTR sequence contains several binding sites for transcription factors such as Sp1, Egr-1, Ets-1, Ap-1, Ap-2, and Ap-4. We have shown that Sp1 is involved in the activation of this promoter. Interestingly, the Sp1 site located at À82/À77 plays a critical role in the p53/p53 site (at 2281/2262)-mediated synergistic transactivation of the p21 promoter (Koutsodontis et al., 2001) . Similarly, conditional formation of transcriptional Sp1-p53 regulatory complexes has been reported recently in a number of other promoters (Borellini and Glazer, 1993; Gualberto and Baldwin, 1995; Ohlsson et al., 1998; Torgeman et al., 2001) . Sp1/p53 synergism may serve as a general mechanism for transcriptional activation of p53 target genes. Therefore, it is tempting to hypothesize that the possible synergism between the p53 site located in À1190 to À1157 of human PTEN promoter and the multiple Sp1 sites located in the 5 0 -UTR region also function on PTEN promoter. On the other hand, multiple consensus Egr-1 sites (GCGGCGGCG) identified in human PTEN promoter (Virolle et al., 2001) were also found in the 5 0 -UTR sequence of mouse PTEN (Figure 9a ). Whether these Egr-1 sites are functional and whether the Sp1 and Egr-1 transcription factors interplay on the promoter in the 5 0 -UTR sequence of PTEN remain to be addressed in future studies. 0 -RACE system for rapid amplification of cDNA ends were purchased from Invitrogen. Oligonucleotides were synthesized by Sigma-Genosys. IMAGE EST clones were obtained from either ATCC or Research Genetics. MAXIscript in vitro transcription kit and RPA III ribonuclease protection assay kit were products of Ambion. TaKaRa LA Taq polymerase with GC buffer was purchased from TaKaRa Bio Inc.
Materials and methods
Materials
Construction of plasmids
The cDNA clone mncb-0146 (GeneBank Accession #: AU035162) was from the Sugano mouse brain mncb library (Suzuki et al., 2000) . Double-strand DNA sequencing showed that this clone encodes the full-length mouse PTEN protein and confirmed that the 5 0 -UTR sequence (À828 to À1) was identical to that shown in GeneBank (Accession # NM_008960). The cDNA, following sequencing, was cloned into pGEM-4Z (Promega) at EcoRI and XbaI sites, resulting in the plasmid pG-WPTEN (Figure 1a ). In the deletion construct pG-DPTEN, the 5 0 -UTR sequence from À828 to À8 was removed by replacing the EcoRI/BglII fragment representing À828 to þ 318 with a PCR fragment representing À8 to þ 318. The plasmid pG-LUC was generated by cloning EcoRI-XbaI fragment of pRF , corresponding to the firefly LUC-encoding region into pGEM-4Z. To generate pG-5 0 LUC, the À828 to À1 of the 5 0 -UTR sequence of mouse PTEN was amplified by PCR and inserted into pG-LUC between the EcoRI and NcoI sites. The 5 0 -UTR deletion mutants of mouse PTEN (À551/À1, À479/ À1, À299/À1) were generated by cloning XhoI-NcoI, NotINcoI, SmaI-NcoI fragments into pG-LUC, respectively. The À257/À1 and À93/À1 deletion mutants were generated by PCR. Dicistronic constructs were generated based on pRF. The 5 0 -UTR sequence of mouse PTEN (À828 to À1) from pG-LUC was cloned into pRF, resulting in pR-PTEN-F. In addition, a 492 bp of the 5 0 -UTR sequence of human PTEN cDNA (À492 to À1) was amplified from human IMAGE 2157760 (GeneBank Accession #: AI480306) and cloned into pRF, resulting in pR-hPTEN-F. Dicistronic constructs with a hairpin structure were generated by inserting into EcoRV site of pRF and pR-PTEN-F a double-stranded oligonucleotide with sense sequence of 5 0 -ATCAAAAGCGCAGGTCGCGACCGCG-CATGCGCGGTCGCGACCTGCGCTAAAGAT-3 0 . The dicistronic constructs containing the truncated 5 0 -UTR of PTEN (À551/À1, À479/À1, À299/À1, À257/À1) were generated by cloning these cDNA fragments from the pG-LUC-based constructs (see above) into pRF. The dicistronic constructs containing other truncations (À828/À220, À828/À348, and À828/À474) were obtained by deletions from pR-PTEN-F between BstXI and NcoI, SmaI and NcoI, and between NotI and NcoI. The À828/À40 construct was generated by cloning a PCR fragment into pRF. The promoterless dicistronic constructs were generated as previously described (Han and Zhang, 2002) .
Constructs containing poly(A) for in vitro transcription were engineered using the vector pSP64 PolyA (Promega) that has 30 bp (dA-dT) sequence. The EcoRV-XbaI fragment of the pRF vector containing the Renilla LUC gene was first cloned into pSP64 PolyA vector at the XbaI and blunted HindIII sites to generate the plasmid pSP-R A30 . The XbaI fragment of pR-HRV-F containing the IRES of HRV and the firefly LUC gene was then isolated and cloned into pSP-R A30 at the XbaI site to generate pSP-R-HRV-F A30 . The pSP-RF A30 plasmid was obtained by removing the IRES sequence of HRV from the pSP-R-HRV-F A30 by digestion with SpeI and NcoI. To engineer pSP-R-PTEN-F A30 , the XhoI-NcoI fragment containing À551 to À1 sequence from pR-PTEN-F was used to replace the HRV IRES fragment in pR-HRV-F A30 construct. All the above constructs were confirmed by double-strand DNA sequencing.
In vitro transcription and translation
In vitro transcription and translation were performed as previously described (Zhang and Ling, 1991) . The pG-WPTEN-, pG-DPTEN-, and pG-LUC-based plasmids were linerized by XbaI and pRF A30 -based plasmids were linearized by EcoRI. The capped transcripts were synthesized in the presence of 1 mm m 7 GpppG and purified using a Qiagen RNeasy Mini kit. Capped RNA transcripts (5-50 ng) were used to program cell-free translation in RRL in a final volume of 10 ml containing 6.5 ml RRL. Translation product was either visualized by autoradiography or by measurement of LUC activities.
Cell culture, DNA and RNA transfection Human HeLa and HEK293 cells were cultured using DMEM, while H1299, K562, DU145, and H226 cells were maintained in RPMI1640, supplemented with 10% fetal bovine serum at 371C with 5% CO 2 . Schneider's Drosophila cell line 2 was maintained in Schneider's Drosophila medium supplemented with 10% fetal bovine serum at room temperature with atmospheric CO 2 .
DNA transfection of human cell lines was performed with Lipofectamine plus reagents according to the manufacturer's protocol. In a 24-well plate, approximately 1 Â 10 5 cells/well were plated and transfected with 0.4 mg DNA. Cells were harvested 24 h following transfection for LUC assay. Transfection of Drosophila SL2 cells was performed according to the protocol as previously described (Han et al., 2001) .
RNA transfection was performed using the cationic liposome-mediated method as previously described (Han and Zhang, 2002) . Briefly, approximately 2 Â 10 5 cells/well were seeded onto six-well plates on the day before transfection. Cells were washed once with Opti-MEM I-reduced serum medium (GIBCO-BRL) and left in the incubator with some medium during preparation of the liposome-polynucleotide complexes. Opti-MEM I medium (1 ml) in a 12 Â 75 mm polystyrene snap-cap tube was mixed with 12.5 mg of Lipofectin reagent and 5 mg capped mRNA. The liposome-RNA-medium mixture was immediately added to cells. At 8 h following transfection, cells were harvested and processed for LUC analysis.
Northern blot analysis
Subconfluent H1299 cells in 10-cm plates were transfected with 4 mg/plate constructs using Lipofectamine Plus. At 24 h following transfection, the total RNAs were extracted using an RNeasy Mini Kit. Residual plasmid DNA in the total RNA was digested with RNase-free DNase. The polyA mRNAs were then isolated from 250 mg of total RNAs using an Oligotex mRNA Mini Kit. One-fifth of the mRNAs were separated in 1% agarose gels in the presence of formaldehyde and MOPS buffer and blotted onto MAGNA nylon membranes. The blots were hybridized with a 32 P-labeled firefly LUC DNA probe (1656 bp), which was isolated by cleaving pRF with NcoI and XbaI and labeled using the Rediprime II Random Prime Labeling System.
5
0 RACE and RNase protection assay 5 0 RACE was performed based on the protocol provided by the supplier. Briefly, 2 mg total RNA from human prostate cancer cell line DU145 was used. The primer used for firststrand cDNA synthesis was GSP1A: 5 0 -TGGCGGTGTCA-TAATGT-3 0 , located in 238 bases downstream of the translation start codon ATG. The primers used for first-round PCR are 5 0 RACE Abridged Anchor Primer from the supplier (36 bases), human PTEN-specific primer GSP2: 5 0 -CCATCCTCTTGATATCTCCTTTTG-3 0 , located 58 bases downstream of the translation start codon ATG. The primers used for the second and final PCR are Abridged Universal Amplification Primer (AUAP) from the supplier and PTENspecific primer PTENEXT1: 5 0 -CCTGTGGCTGAAGAAAA-AGGAGGAGAGAGAT-3 0 , located at 10 bases upstream the translation start codon ATG. Takara Taq polymerase and GC buffer II are used for PCR amplification. The reaction conditions were 941C for 2 min followed by 40 cycles of 941C for 1 min, 551C for 1 min and 721C for 1 min. PCR products were purified from gel, blunted with Klenow enzyme, and then cloned using the PCR Zero Blunt Cloning kit. Individual clones were sequenced for determination of the transcription start sites.
Ribonuclease Protection Assay (RPA) was performed using the RPAIII kit according to the supplier's instructions. Briefly, the RNA probe was produced by first cloning the region of À770 to À60 of human PTEN 5 0 -UTR sequence into PCRBlunt vector at SpeI and XbaI sites. The resulting plasmid was linearized with NotI and transcribed using T7 RNA polymerase in the presence of 0.5 mm each of ATP, GTP, UTP, and 0.01 mm CTP supplemented with 3.12 mm a[ 32 P] CTP. The 32 Plabeled probe was digested with DNase and purified using a Sephadex G-25 Quick Spin Column. About 0.5 Â 10 6 c.p.m. of probe was hybridized to 10 mg total RNA at 451C overnight followed by digestion with RNase T1/A at 371C. The reaction was then stopped and the protected RNAs precipitated before separation by electrophoresis on a 6% acrylamide/8 m urea gel for autoradiography.
Abbreviations SL2, Schneider's Drosophila cell line 2; kb, kilobase(s); PCR, polymerase chain reaction; 5 0 -UTR, 5 0 -untranslated region; IRES, internal ribosome entry site; PAGE, polyacrylamide gel electrophoresis; mRNA, messenger RNA; RRL, rabbit reticulocyte lysate; HRV, human rhinovirus; LUC, luciferase; VEGF, vascular endothelial growth factor; PDGF, plateletderived growth factor.
